Bio-economy valuation practices are not peculiar to that sector.

Evidence

3. While some of these points might sound very much like Sunder Rajan’s (2006) concept of ‘‘biocapital,’’ it is important to emphasize that these valuation practices are not particular to the bio-economy—they are undertaken across sectors. — Kean Birch, Rethinking Value in the Bio-economy, 121

Categorization

• XREF: A key move in the assetization debate: assetization isn’t bio-economy-specific; connects to the reader’s cross-sector assetization framing. — connects to: In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. — Kean Birch, Rethinking Value in the Bio-economy:…, 106; Value in the bio-economy is better theorized through assetization than commodification. — Kean Birch, Rethinking Value in the Bio-economy:…, 112; Value emerges from relational valuation practices, not from objects themselves. — Ève Chiapello, Financialisation of Valuation, 23
• ADDENDUM: Supports de-specializing value analysis beyond ‘biocapital’ toward general assetization — relevant to the foundational assetization article.

Related

• Value in the bio-economy is better theorized through assetization than commodification. (similarity 0.90)
• Value in the bio-economy is produced through valuation practices, not intrinsic to biological matter. (similarity 0.90)
• Value in the bio-economy is managed through asset governance, not product sales. (similarity 0.89)
• Analyzing bio-economy value requires focusing on assets rather than commodities (similarity 0.88)
• Understanding value requires studying the assets underpinning firm valuation, not commodity production. (similarity 0.87)
• Value is not inherent in things but achieved through capitalization practices. (similarity 0.86)
• In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. (similarity 0.86)
• Capitalization builds the thing being valued at the same time it appraises that thing (similarity 0.85)
• Accounting for biological assets reflects chosen methods, not intrinsic biological qualities (similarity 0.84)
• Value is constituted by knowledge and practice, not merely hype. (similarity 0.84)
• Asset value is constituted by active management within organizations, not by biological properties. (similarity 0.84)
• Asset value derives from future earnings rather than intrinsic commodity value (similarity 0.83)
• Value emerges from relational valuation practices, not from objects themselves. (similarity 0.82)
• Capitalization scholarship often treats capital as a living thing embodied in commodities. (similarity 0.81)
• Life sciences firms may never produce products, so valuation is prospective rather than embodied (similarity 0.81)

Broader Connections

• Value emerges from relational valuation practices, not from objects themselves. #expands (0.75) — Ève Chiapello, Financialisation of Valuation, 23